10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole
C40H28N6 — CID 144976056
Data last refreshed: (MolForge compound catalog, from PubChem)
About 10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole
10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole (PubChem CID 144976056) has the molecular formula C40H28N6 and a molecular weight of 592.71 g/mol. Its IUPAC name is 10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole.
Molecular Properties
| Compound Name | 10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole |
|---|---|
| PubChem CID | 144976056 |
| Molecular Formula | C40H28N6 |
| Molecular Weight | 592.71 g/mol |
| Exact Mass | 592.24 |
| IUPAC Name | 10-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]-3-phenyl-5b,9a-dihydropyrazolo[4,5-a]carbazole |
| SMILES | C1=CC2c3ccc4c(cnn4-c4ccccc4)c3N(c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)C2C=C1 |
| InChI | InChI=1S/C40H28N6/c1-4-13-27(14-5-1)38-42-39(28-15-6-2-7-16-28)44-40(43-38)29-17-12-20-31(25-29)45-35-22-11-10-21-32(35)33-23-24-36-34(37(33)45)26-41-46(36)30-18-8-3-9-19-30/h1-26,32,35H |
| InChIKey | VCKCFEDHDZULGD-UHFFFAOYSA-N |
| XLogP | 8.94 |
| TPSA | 59.73 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 592.71 |
| LogP ≤ 5 | 8.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144976056 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.